In an inducible mammary-epithelial-cell targeted Her2 model of breast cancer, a tumor microenvironment inflammatory program driven by TNFα/NFκB signaling promoted immune cell infiltration via CCL5 [45]. The gene discussed is ERBB2; the disease is breast carcinoma.